
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Aug 06, 2026 04:41 am UTC| Business Health
Moderna (NASDAQ: MRNA) has received approval from the U.S. Food and Drug Administration (FDA) for its mRNA-based influenza vaccine, mFLUSIVA, for adults aged 50 and older. The approval marks a significant milestone for the...

Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Aug 05, 2026 08:59 am UTC| Business Health
Novo Nordisk (CSE: NOVOb, NYSE: NVO) raised its full-year 2025 guidance after stronger-than-expected demand for its blockbuster weight-loss drugs helped improve its earnings outlook. The Danish pharmaceutical company now...

New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
Aug 04, 2026 03:23 am UTC| Health Governance
A 2025 measles outbreak in New Mexico cost nearly $5.4 million, highlighting the significant financial burden infectious disease outbreaks place on healthcare systems and public health agencies, according to a new study...

Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Aug 03, 2026 06:02 am UTC| Business Health
Novo Nordisk is showing signs of recovery after a difficult two-year stretch marked by profit warnings, leadership changes, and a sharp decline in its share price. The Danish pharmaceutical giant is gaining renewed...

AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Aug 03, 2026 00:55 am UTC| Business Health
AstraZeneca Plc and Bristol Myers Squibb have reportedly held preliminary discussions about a potential merger that could create one of the worlds largest pharmaceutical companies, with a combined market value approaching...

3 clinical-grade skincare creams you really shouldn’t buy online
Jul 30, 2026 07:38 am UTC| Insights & Views Health
Your social media feed is full of people talking about the holy grail of skincare. Youve Googled, lurked on the Reddit forums and decided its time to try a clinical-grade product. But do you really need a prescription?...

GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Jul 29, 2026 04:11 am UTC| Business Health
GSK has announced a 1.9 billion ($2.52 billion) cost-savings initiative aimed at accelerating drug development and strengthening its long-term growth strategy as the British pharmaceutical giant prepares for the loss of...